{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:16:04Z","timestamp":1783523764578,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009403","name":"Menofia\u00a0University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.intimp.2021.108088","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:38:01Z","timestamp":1629851881000},"page":"108088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation\/NF-\u03baB inhibition"],"prefix":"10.1016","volume":"100","author":[{"given":"Maha H.","family":"Sharawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia H.","family":"El-Kashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina S.","family":"El-Agamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2021.108088_b0005","doi-asserted-by":"crossref","first-page":"e82232","DOI":"10.1371\/journal.pone.0082232","article-title":"Preventive effect of halofuginone on concanavalin A-induced liver fibrosis","volume":"8","author":"Liang","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.intimp.2021.108088_b0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1590\/1414-431x20143704","article-title":"Inhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin A","volume":"47","author":"Wan","year":"2014","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.intimp.2021.108088_b0015","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.intimp.2016.05.024","article-title":"Parthenolide ameliorates Concanavalin A-induced acute hepatitis in mice and modulates the macrophages to an anti-inflammatory state","volume":"38","author":"Wang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.108088_b0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fphar.2018.00292","article-title":"Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis","volume":"9","author":"El-Agamy","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2021.108088_b0025","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/intimm\/11.9.1491","article-title":"Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A","volume":"11","author":"Kimura","year":"1999","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108088_b0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40265-016-0686-9","article-title":"Sitagliptin: A Review in Type 2 Diabetes","volume":"77","author":"Scott","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2021.108088_b0035","doi-asserted-by":"crossref","first-page":"162092","DOI":"10.1155\/2011\/162092","article-title":"Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat)","volume":"2011","author":"Mega","year":"2011","journal-title":"Exp. Diabetes Res."},{"issue":"14","key":"10.1016\/j.intimp.2021.108088_b0040","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/1535370216643418","article-title":"Cardioprotective effects of sitagliptin against doxorubicin-induced cardiotoxicity in rats","volume":"241","author":"El-Agamy","year":"2016","journal-title":"Exp Biol. Med. (Maywood)"},{"key":"10.1016\/j.intimp.2021.108088_b0045","first-page":"339","article-title":"Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus","volume":"8","author":"Omoto","year":"2015","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.intimp.2021.108088_b0050","doi-asserted-by":"crossref","first-page":"6091014","DOI":"10.1155\/2018\/6091014","article-title":"Neuroprotective Activity of Sitagliptin via Reduction of Neuroinflammation beyond the Incretin Effect: Focus on Alzheimer's Disease","volume":"2018","author":"Wici\u0144ski","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.intimp.2021.108088_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabres.2014.04.028","article-title":"Sitagliptin attenuates methionine\/choline-deficient diet-induced steatohepatitis","volume":"105","author":"Jung","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"3","key":"10.1016\/j.intimp.2021.108088_b0060","doi-asserted-by":"crossref","first-page":"e0174295","DOI":"10.1371\/journal.pone.0174295","article-title":"Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity","volume":"12","author":"Abo-Haded","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.intimp.2021.108088_b0065","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s12020-016-1073-8","article-title":"DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-\u03baB activation","volume":"55","author":"Hu","year":"2017","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.intimp.2021.108088_b0070","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.3892\/etm.2016.3255","article-title":"Sitagliptin attenuates inflammatory responses in lipopolysaccharide-stimulated cardiomyocytes via nuclear factor-\u03baB pathway inhibition","volume":"11","author":"Lin","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.intimp.2021.108088_b0075","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2567.2007.02672.x","article-title":"Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects","volume":"122","author":"Tanabe","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2021.108088_b0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.regpep.2014.09.006","article-title":"Analgesic and anti-inflammatory effectiveness of sitagliptin and vildagliptin in mice","volume":"194-195","author":"\u00dajhelyi","year":"2014","journal-title":"Regul. Pept."},{"issue":"2","key":"10.1016\/j.intimp.2021.108088_b0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.intimp.2013.04.007","article-title":"Protective effects of methyl palmitate against silica-induced pulmonary fibrosis in rats","volume":"16","author":"Sharawy","year":"2013","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108088_b0090","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1152\/physrev.1975.55.3.418","article-title":"Posttranslational protein modifications, with special attention to collagen and elastin","volume":"55","author":"Gallop","year":"1975","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2021.108088_b0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2021.108088_b0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.intimp.2021.108088_b0105","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.intimp.2021.108088_b0110","doi-asserted-by":"crossref","unstructured":"M.D. Gorrell, Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders, Clin Sci (Lond, England: 1979) 108(4) (2005) 277-92.","DOI":"10.1042\/CS20040302"},{"issue":"3","key":"10.1016\/j.intimp.2021.108088_b0115","first-page":"729","article-title":"Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism","volume":"5","author":"Miyazaki","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2021.108088_b0120","doi-asserted-by":"crossref","unstructured":"N.A. Trzaskalski, E. Fadzeyeva, E.E. Mulvihill, Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism, Clin Med Insights: Endocrinol Diabetes 13 (2020) 1179551420912972.","DOI":"10.1177\/1179551420912972"},{"issue":"10","key":"10.1016\/j.intimp.2021.108088_b0125","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.molmet.2017.07.016","article-title":"Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease","volume":"6","author":"Baumeier","year":"2017","journal-title":"Mol. Metab."},{"issue":"15","key":"10.1016\/j.intimp.2021.108088_b0130","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3748\/wjg.v19.i15.2298","article-title":"Dipeptidyl peptidase-4: a key player in chronic liver disease","volume":"19","author":"Itou","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108088_b0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2370.2000.00227.x","article-title":"Allele frequencies of polymorphisms of the tumour necrosis factor-alpha, interleukin-10, interferon-gamma and interleukin-2 genes in a North European Caucasoid group from the UK","volume":"27","author":"Reynard","year":"2000","journal-title":"Eur. J. Immunogenet."},{"issue":"4","key":"10.1016\/j.intimp.2021.108088_b0140","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db10-1338","article-title":"Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice","volume":"60","author":"Shirakawa","year":"2011","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.intimp.2021.108088_b0145","first-page":"240","article-title":"Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis","volume":"75","author":"Yilmaz","year":"2012","journal-title":"Acta Gastroenterol. Belg."},{"issue":"9","key":"10.1016\/j.intimp.2021.108088_b0150","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.bbadis.2014.06.004","article-title":"Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2","volume":"1842","author":"Wronkowitz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2021.108088_b0155","first-page":"23","article-title":"Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial","volume":"10","author":"Alam","year":"2018","journal-title":"Hepat. Med.: Evid. Res."},{"issue":"1","key":"10.1016\/j.intimp.2021.108088_b0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bcp.2015.09.001","article-title":"Antifibrotic mechanism of deferoxamine in concanavalin A induced-liver fibrosis: Impact on interferon therapy","volume":"98","author":"Darwish","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2021.108088_b0165","doi-asserted-by":"crossref","first-page":"111501","DOI":"10.1016\/j.ecoenv.2020.111501","article-title":"Exploring the liver fibrosis induced by deltamethrin exposure in quails and elucidating the protective mechanism of resveratrol","volume":"207","author":"Li","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.intimp.2021.108088_b0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.lfs.2019.05.019","article-title":"Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4\/NF-KB signaling pathway in mice","volume":"228","author":"El-Kashef","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2021.108088_b0175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopha.2017.02.010","article-title":"Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats","volume":"89","author":"Sokar","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2021.108088_b0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1042\/bj2620327","article-title":"Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix","volume":"262","author":"Piazza","year":"1989","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.intimp.2021.108088_b0185","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bbrc.2011.05.023","article-title":"The antifibrotic effects of TGF-\u03b21 siRNA on hepatic fibrosis in rats","volume":"409","author":"Lang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2021.108088_b0190","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/acer.12167","article-title":"TGF-\u03b21 up-regulates the expression of PDGF-\u03b2 receptor mRNA and induces a delayed PI3K-, AKT-, and p70(S6K) -dependent proliferative response in activated hepatic stellate cells","volume":"37","author":"Shah","year":"2013","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.108088_b0195","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/gut.2005.088690","article-title":"Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis","volume":"56","author":"Inagaki","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.intimp.2021.108088_b0200","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.intimp.2021.108088_b0205","doi-asserted-by":"crossref","first-page":"e54499","DOI":"10.1371\/journal.pone.0054499","article-title":"Transforming growth factor \u03b2 neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats","volume":"8","author":"Ling","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.intimp.2021.108088_b0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","article-title":"Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats","volume":"49","author":"Kaji","year":"2014","journal-title":"J. Gastroenterol."},{"issue":"25","key":"10.1016\/j.intimp.2021.108088_b0215","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Cicho\u017c-Lach","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.intimp.2021.108088_b0220","doi-asserted-by":"crossref","first-page":"26087","DOI":"10.3390\/ijms161125942","article-title":"The Role of Oxidative Stress and Antioxidants in Liver Diseases","volume":"16","author":"Li","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2021.108088_b0225","doi-asserted-by":"crossref","first-page":"9252","DOI":"10.1039\/D0FO01223H","article-title":"Inflammation response after the cessation of chronic arsenic exposure and post-treatment of natural astaxanthin in liver: potential role of cytokine-mediated cell-cell interactions","volume":"11","author":"Zhang","year":"2020","journal-title":"Food Funct."},{"issue":"3","key":"10.1016\/j.intimp.2021.108088_b0230","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.intimp.2021.108088_b0235","doi-asserted-by":"crossref","first-page":"4234061","DOI":"10.1155\/2016\/4234061","article-title":"Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases","volume":"2016","author":"Li","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"issue":"6","key":"10.1016\/j.intimp.2021.108088_b0240","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3892\/etm.2021.10034","article-title":"Interrelation of inflammation and oxidative stress in liver cirrhosis","volume":"21","author":"Pomacu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2021.108088_b0245","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.toxlet.2021.01.010","article-title":"Depletion of serotonin relieves concanavalin A-induced liver fibrosis in mice by inhibiting inflammation, oxidative stress, and TGF-\u03b21\/Smads signaling pathway","volume":"340","author":"Pang","year":"2021","journal-title":"Toxicol. Lett."},{"issue":"5","key":"10.1016\/j.intimp.2021.108088_b0250","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1002\/jcp.26223","article-title":"Involvement of the Nrf2\/HO-1\/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis","volume":"233","author":"Mangano","year":"2018","journal-title":"J. Cell Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108088_b0255","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1039\/C8FO00378E","article-title":"Protective activity of tovophyllin A, a xanthone isolated from Garcinia mangostana pericarps, against acetaminophen-induced liver damage: role of Nrf2 activation","volume":"9","author":"Ibrahim","year":"2018","journal-title":"Food Fun."},{"key":"10.1016\/j.intimp.2021.108088_b0260","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.lfs.2018.07.019","article-title":"Agmatine attenuates rhabdomyolysis-induced acute kidney injury in rats in a dose dependent manner","volume":"208","author":"Sharawy","year":"2018","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.intimp.2021.108088_b0265","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.cellsig.2011.05.013","article-title":"An I\u03baB\u03b1 phosphorylation inhibitor induces heme oxygenase-1(HO-1) expression through the activation of reactive oxygen species (ROS)-Nrf2-ARE signaling and ROS-PI3K\/Akt signaling in an NF-\u03baB-independent mechanism","volume":"23","author":"Min","year":"2011","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.intimp.2021.108088_b0270","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.intimp.2015.04.032","article-title":"Dihydroquercetin (DHQ) ameliorated concanavalin A-induced mouse experimental fulminant hepatitis and enhanced HO-1 expression through MAPK\/Nrf2 antioxidant pathway in RAW cells","volume":"28","author":"Zhao","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.108088_b0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vph.2015.07.005","article-title":"Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation","volume":"73","author":"Choi","year":"2015","journal-title":"Vascul. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2021.108088_b0280","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jphp.12651","article-title":"Pirfenidone ameliorates concanavalin A-induced hepatitis in mice via modulation of reactive oxygen species\/nuclear factor kappa B signalling pathways","volume":"68","author":"El-Agamy","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108088_b0285","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10753-015-0227-9","article-title":"Quercetin Protects Mice from ConA-Induced Hepatitis by Inhibiting HMGB1-TLR Expression and Down-Regulating the Nuclear Factor Kappa B Pathway","volume":"39","author":"Li","year":"2016","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.intimp.2021.108088_b0290","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s10875-008-9206-3","article-title":"Sodium tanshinone IIA sulfonate protects mice from ConA-induced hepatitis via inhibiting NF-kappaB and IFN-gamma\/STAT1 pathways","volume":"28","author":"Xu","year":"2008","journal-title":"J. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108088_b0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.intimp.2014.11.006","article-title":"Paeoniflorin protects against concanavalin A-induced hepatitis in mice","volume":"24","author":"Chen","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.108088_b0300","doi-asserted-by":"crossref","first-page":"114931","DOI":"10.1016\/j.taap.2020.114931","article-title":"Montelukast ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting TNF-\u03b1\/JNK signaling pathway","volume":"393","author":"El-Kashef","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921007244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921007244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:37:00Z","timestamp":1761586620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921007244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":60,"alternative-id":["S1567576921007244"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108088","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation\/NF-\u03baB inhibition","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108088"}}